The Obesity Paradox in Cancer: Epidemiologic Insights and Perspectives
Authors:
- 25 May 2019
- journal article
- research article
- Published by Springer Nature in Current Nutrition Reports
- Vol. 8 (3) , 175-181
Abstract
Controversy exists whether excess body fatness (measured by body mass index (BMI)) is associated with better cancer survival (“obesity paradox”). Here, we review the obesity paradox in cancer research and discuss potential explanations and future research directions.Keywords
This publication has 62 references indexed in Scilit:
- Importance of Lean Body Mass in the Oncologic PatientNutrition in Clinical Practice, 2012
- Obesity and Ovarian Cancer Survival: A Systematic Review and Meta-analysisCancer Prevention Research, 2012
- Body mass index and survival in patients with renal cell carcinoma: A clinical‐based cohort and meta‐analysisInternational Journal of Cancer, 2012
- Body Mass Index and Risk of Lung Cancer Among Never, Former, and Current SmokersJNCI: Journal of the National Cancer Institute, 2012
- The obesity paradox in chronic disease: facts and numbersJournal of Cachexia, Sarcopenia and Muscle, 2012
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Association between muscular strength and mortality in men: prospective cohort studyBMJ, 2008
- Differentiating between body fat and lean mass—how should we measure obesity?Nature Clinical Practice Endocrinology & Metabolism, 2008
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003